Showing results (91-100 of 174) with videos related to
Sort By:
Pageof 18
Wiener Klinische Wochenschrift|June 28, 2021
Outcomes of an HCV elimination program targeting the Viennese MSM populationMathias Jachs, Teresa Binter, David Chromy, et al.United European Gastroenterology Journal|March 25, 2023
Eligibility for antiviral therapy and treatment uptake in chronic hepatitis B patients referred to a European tertiary care centerMathias Jachs, Raphael Sauberer, Alexander Stiegler, et al.JHEP Reports : Innovation in Hepatology|June 26, 2023
Long-term follow-up of patients discontinuing bulevirtide treatment upon long-term HDV-RNA suppressionMathias Jachs, Marlene Panzer, Lukas Hartl, et al.Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|July 13, 2021
Decreasing von Willebrand Factor Levels Upon Nonselective Beta Blocker Therapy Indicate a Decreased Risk of Further Decompensation, Acute-on-chronic Liver Failure, and DeathMathias Jachs, Lukas Hartl, Benedikt Simbrunner, et al.Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|October 16, 2022
The Sequential Application of Baveno VII Criteria and VITRO Score Improves Diagnosis of Clinically Significant Portal HypertensionMathias Jachs, Lukas Hartl, Benedikt Simbrunner, et al.Alimentary Pharmacology & Therapeutics|July 29, 2024
Prevalence and prognostic value of zinc and selenium deficiency in advanced chronic liver diseaseNina Dominik, Lorenz Balcar, Georg Semmler, et al.Journal of Viral Hepatitis|September 5, 2022
HCV hotline facilitates Hepatitis C elimination during the COVID-19 pandemicLukas Hartl, Mathias Jachs, David Bauer, et al.Gastrointestinal Endoscopy|May 5, 2025
Improved clinical outcomes of patients with cirrhosis and acute variceal bleeding over the last 2 decadesNikolaus Pfisterer, Florian Riedl, Michael Schwarz, et al.JHEP Reports : Innovation in Hepatology|December 21, 2023
Lower free triiodothyronine (fT3) levels in cirrhosis are linked to systemic inflammation, higher risk of acute-on-chronic liver failure, and mortalityLukas Hartl, Benedikt Simbrunner, Mathias Jachs, et al.Digestive Diseases and Sciences|March 18, 2022
Covered Transjugular Intrahepatic Portosystemic Shunt Improves Hypersplenism-Associated Cytopenia in CirrhosisTheresa Bucsics, Katharina Lampichler, Constantin Vierziger, et al.Pageof 18